Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Other Non-Current Assets (2018 - 2025)

Historic Other Non-Current Assets for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to $505.4 million.

  • Takeda Pharmaceutical's Other Non-Current Assets rose 361.74% to $505.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $505.4 million, marking a year-over-year increase of 361.74%. This contributed to the annual value of $461.4 million for FY2025, which is 2992.38% up from last year.
  • As of Q4 2025, Takeda Pharmaceutical's Other Non-Current Assets stood at $505.4 million, which was up 361.74% from $478.7 million recorded in Q3 2025.
  • In the past 5 years, Takeda Pharmaceutical's Other Non-Current Assets registered a high of $948.0 million during Q1 2021, and its lowest value of $345.6 million during Q1 2024.
  • Over the past 5 years, Takeda Pharmaceutical's median Other Non-Current Assets value was $496.6 million (recorded in 2025), while the average stood at $575.0 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first crashed by 3297.36% in 2023, then soared by 5530.35% in 2024.
  • Quarter analysis of 5 years shows Takeda Pharmaceutical's Other Non-Current Assets stood at $700.7 million in 2021, then tumbled by 32.54% to $472.6 million in 2022, then fell by 21.7% to $370.1 million in 2023, then surged by 31.81% to $487.8 million in 2024, then rose by 3.62% to $505.4 million in 2025.
  • Its Other Non-Current Assets stands at $505.4 million for Q4 2025, versus $478.7 million for Q3 2025 and $473.8 million for Q2 2025.